Data / Form D filings / NEUTROLIS INC.
NEUTROLIS INC.: Form D filings
NEUTROLIS INC., a biotechnology company in Cambridge, MA, filed 3 Form D notices with the SEC between 2021 and 2025. The latest, on July 15, 2025, reports $3.5 million sold of a $10 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 BROADWAY, FLOOR 14, Cambridge, MA, 02142
- Phone
- (857) 930-3397
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1788926
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | New notice | $10,000,000 | $3,500,000 | $6,500,000 | 1 | Jun 20, 2025 | sec.gov |
| Apr 8, 2025 | New notice | $1,000,000 | $964,955 | $35,045 | 9 | Feb 28, 2025 | sec.gov |
| Dec 3, 2021 | New notice | $40,636,190 | $23,136,190 | $17,500,000 | 28 | Sep 10, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Hakkim Sundy | Director | |
| Gerald Hakkim Chan | Director | |
| Anthony Hakkim Aiudi | Director, Executive Officer, Promoter | |
| Toby Hakkim Fox | Director, Executive Officer, Promoter | |
| Abdul Hakkim Rahamathullah | Director, Executive Officer, Promoter |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 14, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEUTROLIS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.